Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase I/II Study Evaluating the Safety and Efficacy of Intravenous POL6326 for the Mobilization and Transplantation of HLA-Matched Sibling Donor Hematopoietic Stem Cells in Patients With Advanced Hematological Malignancies

NCT01413568 is registered in ClinicalTrials.gov with Polyphor Ltd. as lead sponsor.

NCT NCT01413568
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01413568 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase I/II Study Evaluating the Safety and Efficacy of Intravenous POL6326 for the Mobilization and Transplantation of HLA-Matched Sibling Donor Hematopoietic Stem Cells in Patients With Advanced Hematological Malignancies
Lead sponsor
Polyphor Ltd.
Phase
Phase 1/2
Overall status
Completed
Start date
April 30, 2012
Completion date
December 31, 2015
Enrollment
38 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

acute myeloid leukemia in remission, adult acute lymphoblastic leukemia in remission, chronic lymphocytic leukemia (cll), chronic myelogenous leukemia (cml), multiple myeloma (mm), myelodysplastic syndrome (mds), myeloproliferative disorders, non-hodgkin's lymphoma (nhl) or hodgkin's disease (hd) in 2nd or greater complete remission, partial remission